IWC
MREO

Integrated Wealth Concepts’s Mereo BioPharma MREO Stock Holding History

Integrated Wealth Concepts’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+1
New – ﹤0.01% 5917

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Integrated Wealth Concepts's MREO Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Mereo BioPharma (MREO) in Q2 2026: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #5917 among its holdings.

61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Integrated Wealth Concepts held 1 share of Mereo BioPharma worth $0 as of Q2 2026.
  • Mereo BioPharma was a new Integrated Wealth Concepts position in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5917 holding.
  • 61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.